Loss of Red Cell A Antigen in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature.
- Author:
Jin Hee CHO
1
;
Mina HUR
;
Hee Won MOON
;
Yeo Min YUN
;
Mark Hong LEE
;
Sung Hee HAN
Author Information
1. Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea. dearmina@hanmail.net
- Publication Type:Case Report
- Keywords:
ABO;
Discrepancy;
Blood group antigen;
Loss;
Acute leukemia
- MeSH:
Adult;
Exons;
Female;
Genotype;
Hematologic Neoplasms;
Humans;
Induction Chemotherapy;
Leukapheresis;
Leukemia;
Leukemia, Myeloid, Acute;
Sepsis;
Tissue Donors;
Transferases
- From:Korean Journal of Blood Transfusion
2011;22(3):277-283
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Red cell antigens, A, B, and H can be weakened or lost especially in patients with hematologic malignancies. We report a 42-year-old female patient with acute myeloid leukemia, who showed loss of A antigen on her red cells. She showed the persistence of leukemia in spite of three cycles of induction chemotherapy. Her ABO blood group showed a discrepancy: the cell type was O and the serum type was A. Adsorption/elution test could not identify the presence of A antigen on her red cells, and the test for A and B transferases was negative. ABO genotyping using PCR/restriction fragment length polymorphism and sequencing of exons 6 and 7 of the ABO gene demonstrated 467 C>T substitution in exon 7 and confirmed the genotype of A102/O01. She was transfused with leukapheresis products collected from donors with blood group A, but expired of severe sepsis. This is the first Korean case, in which red cell A antigen loss was genetically proven using sequencing, and underscores the necessity of ABO genotyping to solve the ABO discrepancy and to transfuse effectively.
